Natasha S. Hochberg, MD, MPH
Voluntary Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Infectious Diseases

MD, Case School of Medicine
MPH, Emory University
BA, Harvard University

Natasha Hochberg, MD, MPH is Volunteer Associate Professor in the Department of Medicine (Section of Infectious Diseases) at the Boston University Chobanian and Avedisian School of Medicine. She sees travelers and patients with tropical diseases in the Center for a infectious Diseases, with a particular focus on Chagas disease and other parasitic infections. Dr. Hochberg previously worked full-time at BU/BMC, but now her primary position is Director, Global Health Translational Medicine at Novartis Institutes for BioMedical Research.

Prior to her arrival at Boston University, Dr. Hochberg was an Epidemic Intelligence Service (EIS) officer at the Centers for Disease and Prevention (CDC) in the Division of Parasitic Diseases and worked internationally on projects related to malaria, visceral leishmaniasis, guinea worm disease, and lymphatic filariasis.

Dr. Hochberg's research focuses on tropical diseases. Particularly, she has studied the impact of malnutrition and parasitic disease on tuberculosis (TB), tropical diseases in immigrant populations, and preventing diseases in international travelers. She was the principal investigator of the TB LION study (Learning the Impact Of Nutrition) in Pondicherry India. This study of household contacts of TB cases evaluates the impact of malnutrition and parasite infections on the immune response to TB and how this changes after providing a high-protein food package, multivitamin, and deworming. She was also site principal investigator of the the US-Indo RePORT study in Pondicherry, India, a cohort of 1100 TB patients and 1500 of their household contacts. The study aimed to identify biomarkers that predict TB treatment failure and risk of developing TB (among exposed persons) and to identify how comorbidities (e.g., diabetes, helminth infections) modulate these profiles and risks. She was co-investigator of an R01 studying TB in pregnancy in IndiA and the recipient of a K-12 BIRCWH award to study the effect of aging on the immune response to latent TB infection in Boston-area nursing home residents.

Previously, she was the co-director of the travel clinic at Boston Medical Center (BMC) and Dire tor of Tropical Medicine. She served as the co-site director for GeoSentinel, an international surveillance system of diseases in travelers and migrants, and participated in studies related to tropical medicine and travelers health. At a national level, she is part of the American Society of Tropical Medicine and Hygiene where she serves as President for the Clinical Group, and previously served as a member of the Scientific Program Committee, a clinical group councilor, and as the Chair for the Subcommittee on Pneumonia, Respiratory Infections and TB.

Dr. Hochberg taught courses at BU School of Public Health on Infectious Disease Epidemiology (EP755) and Outbreak Investigations (EP800).

Novartis Institutes for BioMedical Research
Translational Medicine
Global Health

Chagas Education for Essential Providers
09/30/2020 - 09/29/2025 (Multi-PI)
PI: Natasha S. Hochberg, MD, MPH
Boston Medical Center Corporation HHS CDC
1 NU2GGH002322-01-00

Impact of Personal Exposure to Black Carbon on Pulmonary Tuberculosis Severity
07/01/2014 - 06/30/2018 (PI)
The Potts Memorial Foundation

Chagas Education for Essential Providers YR02
09/30/2020 - 09/29/2025 (PI)
Centers for Disease Control and Prevention/DHHS

Tuberculosis: Learning the Impact of Nutrition
01/01/2018 - 12/31/2022 (PI)
Warren Alpert Foundation

RePORT India Renewal YR03
10/01/2019 - 09/30/2022 (PI)
CRDF Global National Institute o

PRE-NOTIFICATION: Rapid Assay for Circulating T. cruzi Antig
09/01/2021 - 08/31/2022 (PI)
Kephera Diagnostics National Institute o

Immunometabolic and epigenetic effects of obesity on innate immune surveillance in cancer
08/01/2020 - 07/31/2022 (PI)
Brigham and Womens Hospital National Institute o

Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment(PREEMPT)
08/15/2017 - 07/31/2022 (PI)
Trustees of Boston University NIH-NIAID

(Prenotification) VITAL-TB (Vitamins And Latency in Tuberculosis
07/01/2019 - 09/30/2021 (PI)
University of Nebraska Medical Center DOS

Impact of Pregnancy on Tuberculosis
01/01/2019 - 07/31/2021 (PI)
Rutgers, New Jersey Medical School NIH-NIAID

RePORT India Suppl: Effect of Malnutrition on Latent TB
08/18/2017 - 12/31/2020 (PI)
U.S. Civilian Research and Development Foundation National Science Fdn

Determining Barriers to TB Care
06/15/2018 - 12/18/2019 (PI)
Trustees of Boston University US Civ Res & Dev Fdn

Showing 10 of 13 results. Show All Results


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Sinha P, Ponnuraja C, Gupte N, Prakash Babu S, Cox SR, Sarkar S, Mave V, Paradkar M, Cintron C, Govindarajan S, Kinikar A, Priya N, Gaikwad S, Thangakunam B, Devarajan A, Dhanasekaran M, Tornheim JA, Gupta A, Salgame P, Christopher DJ, Kornfeld H, Viswanathan V, Ellner JJ, Horsburgh CR, Gupte AN, Padmapriyadarsini C, Hochberg NS. Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort Analysis. Clin Infect Dis. 2023 Apr 17; 76(8):1483-1491.View Related Profiles. PMID: 36424864; DOI: 10.1093/cid/ciac915;
  2. Van Egeren D, Stoddard M, White LF, Hochberg NS, Rogers MS, Zetter B, Joseph-McCarthy D, Chakravarty A. Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2. Vaccines (Basel). 2023 Apr 16; 11(4).View Related Profiles. PMID: 37112765; PMCID: PMC10143044; DOI: 10.3390/vaccines11040853;
  3. Stoddard M, Yuan L, Sarkar S, Mangalaganesh S, Nolan RP, Bottino D, Hather G, Hochberg NS, White LF, Chakravarty A. Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy. Vaccines (Basel). 2023 Apr 06; 11(4).View Related Profiles. PMID: 37112718; PMCID: PMC10140995; DOI: 10.3390/vaccines11040806;
  4. Hochberg NS, Montgomery SP. Chagas Disease. Ann Intern Med. 2023 Feb; 176(2):ITC17-ITC32. PMID: 36780647
  5. Wang X, VanValkenberg A, Odom-Mabey AR, Ellner JJ, Hochberg NS, Salgame P, Patil P, Johnson WE. Comparison of gene set scoring methods for reproducible evaluation of multiple tuberculosis gene signatures. bioRxiv. 2023 Jan 30. PMID: 36711818; PMCID: PMC9882404; DOI: 10.1101/2023.01.19.520627;
  6. DiLorenzo MA, Davis MR, Dugas JN, Nelson KP, Hochberg NS, Ingalls RR, Mishuris RG, Schechter-Perkins EM. Performance of three screening tools to predict COVID-19 positivity in emergency department patients. Emerg Med J. 2023 Mar; 40(3):210-215.View Related Profiles. PMID: 36596666
  7. Knudsen S, Babu SP, Ramakrishnan J, Jenkins HE, Joseph N, Cintron C, Narasimhan PB, Salgame P, Hochberg NS, Hom DL, Ellner J, Horsburgh CR, Sarkar S. M. tuberculosis infection before, during and after pregnancy. Int J Tuberc Lung Dis. 2023 Jan 01; 27(1):72-74.View Related Profiles. PMID: 36853122
  8. Van Egeren D, Stoddard M, Malakar A, Ghosh D, Acharya A, Mainuddin S, Majumdar B, Luo D, Nolan RP, Joseph-McCarthy D, White LF, Hochberg NS, Basu S, Chakravarty A. No magic bullet: Limiting in-school transmission in the face of variable SARS-CoV-2 viral loads. Front Public Health. 2022; 10:941773.View Related Profiles. PMID: 36530725; PMCID: PMC9751474; DOI: 10.3389/fpubh.2022.941773;
  9. Kalva J, Babu SP, Narasimhan PB, Raghupathy K, Ezhumalai K, Knudsen S, Horsburgh CR, Hochberg N, Salgame P, Roy G, Ellner J, Sarkar S. Predictors of weight loss during the intensive phase of tuberculosis treatment in patients with drug-susceptible pulmonary tuberculosis in South India. J Public Health (Oxf). 2022 Nov 30.View Related Profiles. PMID: 36451280
  10. VanValkenburg A, Kaipilyawar V, Sarkar S, Lakshminarayanan S, Cintron C, Babu SP, Knudsen S, Joseph NM, Horsburgh CR, Sinha P, Ellner JJ, Narasimhan PB, Johnson WE, Hochberg NS, Salgame P. Corrigendum: Malnutrition leads to increased inflammation and expression of tuberculosis risk signatures in recently exposed household contacts of pulmonary tuberculosis. Front Immunol. 2022; 13:1064883.View Related Profiles. PMID: 36341454; PMCID: PMC9632611; DOI: 10.3389/fimmu.2022.1064883;
Showing 10 of 91 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 90 publications over 21 distinct years, with a maximum of 20 publications in 2021

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Emigrants and Immigrants
Chagas Disease
Immune Response, Innate

Dr. Hochberg has an active interest in mentoring. She has mentored more than 35 clinical fellows, medical residents, medical students, PhD candidates, and Masters in Public Health students. Trainees have been involved in literature reviews, developing independent projects, assisting with data analyses, developing presentations, and writing manuscripts. The majority of these mentees have presented abstracts or co-authored manuscripts with Dr. Hochberg. Dr. Hochberg enjoys involving trainees in research and giving them the skills to progress in academia.

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Co-Mentor or Peer Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

715 Albany St Talbot Building
Boston MA 02118
Google Map

Hochberg's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department